SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001203311-21-000036
Filing Date
2021-05-18
Accepted
2021-05-18 19:35:19
Documents
1
Period of Report
2021-05-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 5446
  Complete submission text file 0001203311-21-000036.txt   6937
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
Seagen Inc. (Issuer) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SYROS PHARMACEUTICALS, INC. 620 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Simonian Nancy A (Reporting) CIK: 0001359574 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-32405 | Film No.: 21937889